Frequency of antigens expression and epstein-barr virus on diffuse large b-cell lymphoma by Lee, K.K. et al.
12th Biological Sciences Graduate Congress
17-19 December 2007
University of Malaya
I B-P221
Frequency of Antigens Expression and Epstein-Barr Virus
on Diffuse Large B-Cell Lymphoma
L.K. Lee, K.K. Wong, E.S. Lee and s.c. Peh
Departments of Pathology, Faculty of Medicine, University of Malaya,
50603 Kuala Lumpur, Malaysia
Diffuse large B-celllymphoma (DLBCL) is the most common type of malignant
non-Hodgkin's lymphoma. It can be further divided into two subgroups: germinal
centre B-cells (GCB) derived DLBCLand non-GCB derived DLBCLbased on cDNA
microarray and immunohistochemical markers studies. However, DNAmicroarray
profiling is not within reach of most diagnostic laboratories for the benefits of
patients, in view of the high capital and running costs, and the requirement of
highly trained operating personnel. The aim of this study is to evaluate the use
of immunohistochemical markers to subdivide DLBCLsinto prognostic subgroups
among Malaysian patients. A total of 110 DLBCLcases between 1983 and 2006
were studied for expression of BCL-2, BCL-6, CD10, CD138 and MUM-l by
immunohistochemistry. Epstein-Barr virus (EBV)-encoded small RNA (EBER) in
situ hybridization was employed to determine the presence of EBV. We found
that ethnic Malays accounted for the largest number of patients (49/110,44.5%),
followed by Chinese (47/110,42.7%), Indians (13/110, 11.8%) and minority
ethnic (1/110, 0.9%). Of these cases, 41 (37.3%) were shown to be GCBsubgroup
and the others 69 (62.7%) non-GCB subgroup. The GCB: non-GCB ratio is
approximately 1: 1.7. Only six cases (5.6%) were found to be EBER positive.
These findings suggests that BCL-6, CD10 and MUM-l are suitable
immunohistochemical markers to distinguish the DLBCLsubgroups and easy to
apply. The technique of immunohistochemical stain maybe able to provide
prognostic information as performed by cDNA microarray.
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